Bioliberty develops soft robotic exoskeletons designed to restore mobility for individuals recovering from injuries or living with mobility-limiting conditions. Their technology aims to provide personalized support and assistance, empowering users to regain independence and improve their quality of life.
Funding
$435K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IUFounders
Product
Problem
Physical and occupational therapy services face rising costs, staffing shortages, and increasing demand from patients with mobility impairments such as post‑stroke deficits, limiting the amount and intensity of therapy that can be delivered.
Solution
Bioliberty addresses these constraints with Lifehub Clinic, a platform that combines soft‑robotic wearables, gamified therapy exercises, and AI‑driven analytics. The system enables clinicians to prescribe high‑dose, high‑intensity upper‑extremity therapy that can be administered more efficiently, reducing therapist time per session while maintaining therapeutic effectiveness. Gamified activities keep patients engaged, and real‑time data collection provides objective progress metrics that support evidence‑based documentation and treatment adjustments. By integrating these components into a single workflow, the platform helps therapy providers expand capacity, improve outcomes, and lower operational costs.
Target Audience
Primary customers are physical and occupational therapy clinics, rehabilitation centers, and hospitals seeking to increase therapy throughput and improve outcomes for patients with upper‑extremity mobility impairments.
Features
- Soft‑robotic wearable (Lifeglov) that delivers assisted movement for a range of hand function levels
- Adaptive, gamified therapy modules that personalize difficulty and maintain patient motivation
- AI analytics dashboard that aggregates performance data, tracks longitudinal progress, and generates documentation reports
- High‑intensity therapy mode designed to maximize therapeutic dose within shorter session times
- Modular therapy modes allowing clinicians to tailor protocols to individual patient needs and mobility levels